Resultado de búsqueda
Following the acquisition, Novo Nordisk would aim to preserve the agility and entrepreneurial spirit of BIOCORP, while investing further in the organization with the goal of delivering cutting edge devices and delivery solutions to improve care for people across the globe living with serious chronic diseases.
27 de sept. de 2021 · BIOCORP (Paris:ALCOR) (FR0012788065 – ALCOR / Eligible PEA PME), a French company specialized in the design, development, and manufacturing of innovative medical devices, today announces an...
5 de jun. de 2023 · June 5 (Reuters) - Danish drug developer Novo Nordisk said on Monday it had started talks to buy a controlling stake in French medical device designer Biocorp (ALCOR.PA).
6 de jun. de 2023 · On Monday, June 5, medical device manufacturer Biocorp announced that it had been acquired by Danish giant Novo Nordisk for €154 million. The Danish pharmaceutical company will first acquire...
26 de oct. de 2022 · BIOCORP (FR0012788065 – ALCOR / Eligible PEA‐PME) (Paris:ALCOR), a French company specialized in the design, development, and manufacturing of innovative medical devices, announces the signature...
5 de jun. de 2023 · MedTech. Novo Nordisk offers €154M in negotiations to acquire diabetes devicemaker Biocorp. By Andrea Park Jun 5, 2023 9:55am. Novo Nordisk mergers and acquisitions Insulin pen Diabetes....
4 de ago. de 2023 · Following the announcement of the planned acquisition of BIOCORP Production SA (FR0012788065 - ALCOR) (“ BIOCORP ”) by NOVO NORDISK (DK0060534915 - Novo-B), a leading global healthcare...
